• Search
  • Advanced Search
Clin Mol Hepatol > Accepted Articles
Letter to the Editor
Presence of liver fibrosis in chronic hepatitis B patients with varying serum HBV DNA levels
Jian Wang1,2, Shaoqiu Zhang1, Chuanwu Zhu3, Yuanwang Qiu4, Chao Wu1,2, Rui Huang1,2
1Department of Infectious Diseases, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China
2Institute of Viruses and Infectious Diseases, Nanjing University, Nanjing, Jiangsu, China
3Department of Infectious Diseases, The Affiliated Infectious Diseases Hospital of Soochow University, Suzhou, Jiangsu, China
4Department of Infectious Diseases, The Fifth People’s Hospital of Wuxi, Wuxi, Jiangsu, China
Correspondence :  Rui Huang ,
Email: doctor_hr@126.com
Received: July 26, 2024  Revised: August 5, 2024   Accepted: August 5, 2024
TOOLS
METRICS Graph View
  • 0 Crossref
  •  0 Scopus
  • 227 View
  • 14 Download
Related articles

Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy2024 July;30(3)

Cardiovascular risk in chronic hepatitis B patients treated with tenofovir disoproxil fumarate or tenofovir alafenamide2024 January;30(1)

Dyslipidemia in chronic hepatitis B patients on tenofovir alafenamide: Facts and puzzles2022 April;28(2)

Entecavir+tenofovir vs. lamivudine/telbivudine+adefovir in chronic hepatitis B patients with prior suboptimal response2020 July;26(3)

Assessment of fibrotic burden among chronic hepatitis B virus-infected patients with normal transaminase level 2018 December;24(4)

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 612
TOTAL : 2085280
Close layer